Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gynecological Cancers × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 47 Lymphoma 41 HIV Infections 11 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 8 Lymphoma, Non-Hodgkin 8 Sarcoma, Kaposi 7 Neoplasms 6 Head and Neck Neoplasms 6 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5 Endodermal Sinus Tumor 5 Testicular Germ Cell Tumor 4 Recurrence 4 Ovarian Germ Cell Cancer 4 Neoplasms, Germ Cell and Embryonal 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Carcinoma, Embryonal 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Seminoma 3 Ovarian Neoplasms 3 Teratoma, Testicular 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Dendritic Cell Sarcoma, Interdigitating 2 Central Nervous System Neoplasms 2 Cardiotoxicity 2

Interventions

Pharmaceutical Preparations 1 Electroporation 1 Electrochemotherapy 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡